Meet Your ETF AI Analyst
- Discover how TipRanks' ETF AI Analyst can help you make smarter investment decisions
- Explore ETFs TipRanks' users love and see what insights the ETF AI Analyst reveals about the ones you follow.
Innovative Pharmaceutical Biotech ( (HK:0399) ) just unveiled an update.
Starcoin Group Limited has issued a clarification regarding an online media article that falsely claimed the company had entered into a merger and acquisition agreement with Tianxingjian Health Industry Group. The company firmly denies any such agreement or affiliation with Tianxingjian and reserves the right to pursue legal action to protect its interests and those of its shareholders. Shareholders and potential investors are advised to rely only on official company announcements and exercise caution when dealing with the company’s securities.
More about Innovative Pharmaceutical Biotech
Starcoin Group Limited, formerly known as Innovative Pharmaceutical Biotech Limited, is incorporated in the Cayman Islands and continued in Bermuda with limited liability. The company operates in the pharmaceutical and biotech industry, focusing on innovative solutions and products.
Average Trading Volume: 22,169,248
Technical Sentiment Signal: Buy
Current Market Cap: HK$642.8M
For an in-depth examination of 0399 stock, go to TipRanks’ Overview page.